SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'LP1'


List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C6Y_B_MK1B524_1
(PROTEIN (PROTEASE))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  53
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.80A 1c6yA-2fmbA:
15.2		 1c6yA-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C6Y_B_MK1B524_1
(PROTEIN (PROTEASE))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.85A 1c6yA-2fmbA:
15.2		 1c6yA-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C6Y_B_MK1B524_1
(PROTEIN (PROTEASE))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.65A 1c6yA-2fmbA:
15.2		 1c6yA-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C6Y_B_MK1B524_2
(PROTEIN (PROTEASE))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.35A 1c6yB-2fmbA:
15.2		 1c6yB-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C6Y_B_MK1B524_2
(PROTEIN (PROTEASE))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.62A 1c6yB-2fmbA:
15.2		 1c6yB-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C6Z_B_ROCB505_1
(PROTEIN (PROTEASE))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.61A 1c6zA-2fmbA:
15.3		 1c6zA-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C6Z_B_ROCB505_1
(PROTEIN (PROTEASE))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.77A 1c6zA-2fmbA:
15.3		 1c6zA-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C6Z_B_ROCB505_1
(PROTEIN (PROTEASE))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.57A 1c6zA-2fmbA:
15.3		 1c6zA-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C6Z_B_ROCB505_2
(PROTEIN (PROTEASE))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.66A 1c6zB-2fmbA:
15.4		 1c6zB-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C6Z_B_ROCB505_2
(PROTEIN (PROTEASE))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.66A 1c6zB-2fmbA:
15.4		 1c6zB-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C6Z_B_ROCB505_2
(PROTEIN (PROTEASE))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.81A 1c6zB-2fmbA:
15.4		 1c6zB-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1D4S_A_TPVA201_1
(PROTEIN (HIV-1
PROTEASE))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.55A 1d4sA-2fmbA:
14.8		 1d4sA-2fmbA:
28.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1D4S_A_TPVA201_2
(PROTEIN (HIV-1
PROTEASE))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 8 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  55
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
 0.45A 1d4sB-2fmbA:
15.1		 1d4sB-2fmbA:
28.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4Y_A_TPVA501_1
(PROTEIN (HIV-1
PROTEASE))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  53
GLY A  55
VAL A  87
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.58A 1d4yA-2fmbA:
15.1		 1d4yA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4Y_A_TPVA501_2
(PROTEIN (HIV-1
PROTEASE))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 8 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  55
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.53A 1d4yB-2fmbA:
15.2		 1d4yB-2fmbA:
33.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.38A 1fb7A-2fmbA:
15.2		 1fb7A-2fmbA:
29.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HPV_B_478B200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 LEU A  23
ASP A  25
GLY A  27
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.73A 1hpvA-2fmbA:
15.4		 1hpvA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HPV_B_478B200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.68A 1hpvA-2fmbA:
15.4		 1hpvA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HPV_B_478B200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 ASP A  25
ALA A  28
VAL A  32
GLY A  54
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.84A 1hpvB-2fmbA:
15.5		 1hpvB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HPV_B_478B200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.50A 1hpvB-2fmbA:
15.5		 1hpvB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  53
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.64A 1hsgA-2fmbA:
15.3		 1hsgA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.74A 1hsgA-2fmbA:
15.3		 1hsgA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 10 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.54A 1hsgA-2fmbA:
15.3		 1hsgA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ALA A  28
ASP A  29
GLY A  54
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.85A 1hsgB-2fmbA:
15.2		 1hsgB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.40A 1hsgB-2fmbA:
15.2		 1hsgB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_A_MK1A401_1
(HIV-II PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.80A 1hshA-2fmbA:
15.6		 1hshA-2fmbA:
37.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_A_MK1A401_1
(HIV-II PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.30A 1hshA-2fmbA:
15.6		 1hshA-2fmbA:
37.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_A_MK1A401_2
(HIV-II PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ASP A  25
ALA A  28
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.45A 1hshB-2fmbA:
15.7		 1hshB-2fmbA:
37.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.34A 1hshC-2fmbA:
15.9		 1hshC-2fmbA:
37.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_2
(HIV-II PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 8 ARG A   8
ASP A  25
ALA A  28
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.55A 1hshD-2fmbA:
15.9		 1hshD-2fmbA:
37.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_2
(HIV-II PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		4 / 8 ASP A  25
ALA A  28
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.71A 1hshD-2fmbA:
15.9		 1hshD-2fmbA:
37.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  54
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.52A 1hxbA-2fmbA:
15.2		 1hxbA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.60A 1hxbB-2fmbA:
15.1		 1hxbB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.71A 1hxbB-2fmbA:
15.1		 1hxbB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.60A 1hxbB-2fmbA:
15.1		 1hxbB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 ASP A  25
GLY A  27
ASP A  29
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.44A 1hxwA-2fmbA:
15.1		 1hxwA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ASP A  25
GLY A  27
GLY A  54
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.71A 1hxwA-2fmbA:
15.1		 1hxwA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 11 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
PRO A  86
VAL A  87
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.55A 1hxwB-2fmbA:
15.0		 1hxwB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
 1.05A 1hxwB-2fmbA:
15.0		 1hxwB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  53
GLY A  54
PRO A  86
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
 0.64A 1k6cA-2fmbA:
15.2		 1k6cA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  54
GLY A  55
PRO A  86
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.46A 1k6cA-2fmbA:
15.2		 1k6cA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_2
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ARG A   8
ASP A  25
GLY A  27
ASP A  29
GLY A  55
PRO A  86
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.64A 1k6cB-2fmbA:
15.2		 1k6cB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_2
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
 0.84A 1k6cB-2fmbA:
15.2		 1k6cB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_2
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.31A 1k6cB-2fmbA:
15.2		 1k6cB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.84A 1muiA-2fmbA:
15.3		 1muiA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.52A 1muiA-2fmbA:
15.3		 1muiA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.56A 1muiB-2fmbA:
15.1		 1muiB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.79A 1muiB-2fmbA:
15.1		 1muiB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.53A 1muiB-2fmbA:
15.1		 1muiB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_B_RITB301_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		4 / 7 ASP A  29
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.39A 1n49A-2fmbA:
15.2		 1n49A-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_B_RITB301_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 ARG A   8
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.86A 1n49B-2fmbA:
14.9		 1n49B-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_D_RITD401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 ARG A   8
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.84A 1n49C-2fmbA:
14.7		 1n49C-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_D_RITD401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		4 / 6 ASP A  29
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.40A 1n49D-2fmbA:
15.2		 1n49D-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_1
(ASPARTYLPROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.95A 1ohrA-2fmbA:
15.3		 1ohrA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_1
(ASPARTYLPROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.35A 1ohrA-2fmbA:
15.3		 1ohrA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_2
(ASPARTYLPROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 ASP A  25
VAL A  32
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.90A 1ohrB-2fmbA:
15.0		 1ohrB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_2
(ASPARTYLPROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 9 LEU A  23
ASP A  25
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.56A 1ohrB-2fmbA:
15.0		 1ohrB-2fmbA:
30.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RL8_A_RITA9001_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.53A 1rl8A-2fmbA:
15.0		 1rl8A-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RL8_A_RITA9001_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.71A 1rl8A-2fmbA:
15.0		 1rl8A-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RL8_A_RITA9001_2
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.58A 1rl8B-2fmbA:
15.0		 1rl8B-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RL8_A_RITA9001_2
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.67A 1rl8B-2fmbA:
15.0		 1rl8B-2fmbA:
29.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 ARG A   8
LEU A  23
ASP A  25
ILE A  53
GLY A  54
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.60A 1sdtA-2fmbA:
14.9		 1sdtA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 LEU A  23
ASP A  25
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.82A 1sdtA-2fmbA:
14.9		 1sdtA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
ILE A  53
GLY A  54
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.61A 1sdtA-2fmbA:
14.9		 1sdtA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.46A 1sdtB-2fmbA:
14.9		 1sdtB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 11 LEU A  23
ASP A  25
ALA A  28
ILE A  53
GLY A  54
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.51A 1sduA-2fmbA:
15.0		 1sduA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.49A 1sduB-2fmbA:
15.2		 1sduB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  53
GLY A  54
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.58A 1sdvA-2fmbA:
15.0		 1sdvA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 ASP A  25
ALA A  28
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.81A 1sdvA-2fmbA:
15.0		 1sdvA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
ALA A  28
ILE A  53
GLY A  54
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.50A 1sdvA-2fmbA:
15.0		 1sdvA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 ASP A  25
ALA A  28
ASP A  29
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.92A 1sdvB-2fmbA:
14.9		 1sdvB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.53A 1sdvB-2fmbA:
14.9		 1sdvB-2fmbA:
33.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SGU_B_MK1B2632_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 8 ASP A  25
ALA A  28
ILE A  53
GLY A  54
GLY A  55
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.38A 1sguA-2fmbA:
15.2		 1sguA-2fmbA:
27.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SGU_B_MK1B2632_2
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.49A 1sguB-2fmbA:
15.2		 1sguB-2fmbA:
27.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SH9_B_RITB301_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 8 ASP A  25
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.42A 1sh9A-2fmbA:
15.3		 1sh9A-2fmbA:
27.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SH9_B_RITB301_2
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 ASP A  25
GLY A  27
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.36A 1sh9B-2fmbA:
15.3		 1sh9B-2fmbA:
27.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
 0.80A 1t3rA-2fmbA:
15.0		 1t3rA-2fmbA:
34.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.59A 1t3rA-2fmbA:
15.0		 1t3rA-2fmbA:
34.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.13A 1t3rB-2fmbA:
15.1		 1t3rB-2fmbA:
34.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.58A 1t3rB-2fmbA:
15.1		 1t3rB-2fmbA:
34.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7I_A_017A200_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
 0.80A 1t7iA-2fmbA:
15.1		 1t7iA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7I_A_017A200_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
 0.46A 1t7iA-2fmbA:
15.1		 1t7iA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7I_A_017A200_2
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		4 / 7 ASP A  25
ALA A  28
VAL A  32
GLY A  55
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
 0.29A 1t7iB-2fmbA:
14.8		 1t7iB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7J_A_478A200_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
 0.77A 1t7jA-2fmbA:
15.1		 1t7jA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7J_A_478A200_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
 0.48A 1t7jA-2fmbA:
15.1		 1t7jA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7J_A_478A200_2
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		4 / 7 ASP A  25
ALA A  28
VAL A  32
GLY A  55
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
 0.32A 1t7jB-2fmbA:
15.0		 1t7jB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOF_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		4 / 5 ASP A  25
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.35A 2aofA-2fmbA:
15.0		 2aofA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOF_C_FRDC305_2
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		4 / 5 LEU A  23
ASP A  25
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.45A 2aofB-2fmbA:
14.9		 2aofB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOH_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		4 / 5 LEU A  23
ASP A  25
GLY A  55
PRO A  86
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.48A 2aohA-2fmbA:
15.0		 2aohA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOH_C_FRDC305_2
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		4 / 5 LEU A  23
ASP A  25
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.33A 2aohB-2fmbA:
15.0		 2aohB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOI_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 5 ASP A  25
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.56A 2aoiA-2fmbA:
14.8		 2aoiA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOI_C_FRDC305_2
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 5 LEU A  23
ASP A  25
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.57A 2aoiB-2fmbA:
15.0		 2aoiB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOJ_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 5 LEU A  23
ASP A  25
GLY A  55
PRO A  86
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.50A 2aojA-2fmbA:
14.9		 2aojA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOJ_C_FRDC305_2
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 7 LEU A  23
ASP A  25
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.41A 2aojB-2fmbA:
15.1		 2aojB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.44A 2aquA-2fmbA:
15.1		 2aquA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.86A 2aquA-2fmbA:
15.1		 2aquA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.51A 2aquB-2fmbA:
15.0		 2aquB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.89A 2aquB-2fmbA:
15.0		 2aquB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVO_B_MK1B902_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 ARG A   8
LEU A  23
ASP A  25
ILE A  53
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.76A 2avoA-2fmbA:
14.8		 2avoA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVO_B_MK1B902_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 LEU A  23
ASP A  25
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.73A 2avoA-2fmbA:
14.8		 2avoA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVO_B_MK1B902_2
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.85A 2avoB-2fmbA:
15.2		 2avoB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVO_B_MK1B902_2
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.41A 2avoB-2fmbA:
15.2		 2avoB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ILE A  53
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-4.6A)
LP1  A 201 (-4.2A)
 0.65A 2avsA-2fmbA:
15.0		 2avsA-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  54
GLY A  55
VAL A  56
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-4.2A)
 0.55A 2avsA-2fmbA:
15.0		 2avsA-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_3
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
VAL A  56
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.45A 2avsB-2fmbA:
15.2		 2avsB-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ILE A  53
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-4.6A)
 0.61A 2avvA-2fmbA:
15.3		 2avvA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  53
GLY A  54
GLY A  55
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.48A 2avvA-2fmbA:
15.3		 2avvA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_2
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		3 / 3 ASP A  29
VAL A  32
PRO A  86
 LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.9A)
 0.56A 2avvA-2fmbA:
15.3		 2avvA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_3
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.88A 2avvB-2fmbA:
15.3		 2avvB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_3
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.54A 2avvB-2fmbA:
15.3		 2avvB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ILE A  53
GLY A  54
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
 0.62A 2avvD-2fmbA:
15.3		 2avvD-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  54
GLY A  55
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
 1.29A 2avvD-2fmbA:
15.3		 2avvD-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  53
GLY A  54
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.46A 2avvD-2fmbA:
15.3		 2avvD-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  54
GLY A  55
PRO A  86
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.55A 2avvD-2fmbA:
15.3		 2avvD-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_3
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ALA A  28
ASP A  29
GLY A  54
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.85A 2avvE-2fmbA:
15.3		 2avvE-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_3
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.47A 2avvE-2fmbA:
15.3		 2avvE-2fmbA:
33.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2B60_B_RITB100_1
(GAG-POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 1.05A 2b60A-2fmbA:
15.2		 2b60A-2fmbA:
28.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2B60_B_RITB100_1
(GAG-POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.50A 2b60A-2fmbA:
15.2		 2b60A-2fmbA:
28.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2B60_B_RITB100_1
(GAG-POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.58A 2b60A-2fmbA:
15.2		 2b60A-2fmbA:
28.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2B60_B_RITB100_2
(GAG-POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.30A 2b60B-2fmbA:
15.2		 2b60B-2fmbA:
28.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2B60_B_RITB100_2
(GAG-POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.41A 2b60B-2fmbA:
15.2		 2b60B-2fmbA:
28.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2B60_B_RITB100_2
(GAG-POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 11 ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.57A 2b60B-2fmbA:
15.2		 2b60B-2fmbA:
28.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2B7Z_B_MK1B200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.40A 2b7zA-2fmbA:
15.2		 2b7zA-2fmbA:
27.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2B7Z_B_MK1B200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.54A 2b7zB-2fmbA:
15.1		 2b7zB-2fmbA:
27.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BPX_B_MK1B902_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.91A 2bpxB-2fmbA:
15.0		 2bpxB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BPX_B_MK1B902_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.56A 2bpxB-2fmbA:
15.0		 2bpxB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.35A 2f80A-2fmbA:
15.0		 2f80A-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_2
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.40A 2f80B-2fmbA:
15.0		 2f80B-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.39A 2f81A-2fmbA:
14.9		 2f81A-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_2
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.39A 2f81B-2fmbA:
15.0		 2f81B-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
VAL A  56
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.41A 2f8gA-2fmbA:
15.0		 2f8gA-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_2
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.90A 2f8gB-2fmbA:
15.0		 2f8gB-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_2
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
VAL A  56
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.50A 2f8gB-2fmbA:
15.0		 2f8gB-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_1
(POL PROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
 0.37A 2fxdA-2fmbA:
15.2		 2fxdA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_2
(POL PROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 7 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  55
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
 0.39A 2fxdB-2fmbA:
14.8		 2fxdB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_2
(POL PROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 7 ASP A  25
ALA A  28
ASP A  29
GLY A  55
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.50A 2fxdB-2fmbA:
14.8		 2fxdB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_1
(POL PROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.54A 2fxeA-2fmbA:
15.0		 2fxeA-2fmbA:
35.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_1
(POL PROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.92A 2fxeA-2fmbA:
15.0		 2fxeA-2fmbA:
35.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_1
(POL PROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.68A 2fxeA-2fmbA:
15.0		 2fxeA-2fmbA:
35.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_2
(POL PROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.58A 2fxeB-2fmbA:
15.4		 2fxeB-2fmbA:
35.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_2
(POL PROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.89A 2fxeB-2fmbA:
15.4		 2fxeB-2fmbA:
35.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.47A 2hs1A-2fmbA:
14.8		 2hs1A-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
ALA A  28
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.85A 2hs1B-2fmbA:
15.0		 2hs1B-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.36A 2hs1B-2fmbA:
15.0		 2hs1B-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.40A 2hs2A-2fmbA:
14.9		 2hs2A-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.25A 2hs2B-2fmbA:
15.0		 2hs2B-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.53A 2idwA-2fmbA:
14.9		 2idwA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 1.26A 2idwB-2fmbA:
15.2		 2idwB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.78A 2idwB-2fmbA:
15.2		 2idwB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.42A 2idwB-2fmbA:
15.2		 2idwB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 1.28A 2ienA-2fmbA:
15.0		 2ienA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.87A 2ienA-2fmbA:
15.0		 2ienA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.46A 2ienA-2fmbA:
15.0		 2ienA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.46A 2ienB-2fmbA:
15.0		 2ienB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.52A 2ieoA-2fmbA:
15.0		 2ieoA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
 0.93A 2ieoA-2fmbA:
15.0		 2ieoA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.49A 2ieoB-2fmbA:
15.0		 2ieoB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.58A 2nmyA-2fmbA:
14.5		 2nmyA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.81A 2nmyA-2fmbA:
14.5		 2nmyA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  55
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.44A 2nmyB-2fmbA:
14.7		 2nmyB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.63A 2nmyB-2fmbA:
14.7		 2nmyB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.51A 2nmyB-2fmbA:
14.7		 2nmyB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMZ_B_ROCB401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.97A 2nmzA-2fmbA:
15.0		 2nmzA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMZ_B_ROCB401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.45A 2nmzA-2fmbA:
15.0		 2nmzA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMZ_B_ROCB401_3
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.61A 2nmzB-2fmbA:
15.1		 2nmzB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMZ_B_ROCB401_3
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.71A 2nmzB-2fmbA:
15.1		 2nmzB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  54
PRO A  86
VAL A  87
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 1.08A 2nnkA-2fmbA:
14.9		 2nnkA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.56A 2nnkA-2fmbA:
14.9		 2nnkA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_3
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  29
GLY A  55
PRO A  86
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 1.39A 2nnkB-2fmbA:
14.9		 2nnkB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_3
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.58A 2nnkB-2fmbA:
14.9		 2nnkB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
PRO A  86
VAL A  87
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.93A 2nnpA-2fmbA:
14.9		 2nnpA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.53A 2nnpA-2fmbA:
14.9		 2nnpA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.69A 2nnpB-2fmbA:
15.3		 2nnpB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.62A 2nnpB-2fmbA:
15.3		 2nnpB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.76A 2o4kA-2fmbA:
15.0		 2o4kA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  53
GLY A  54
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.42A 2o4kA-2fmbA:
15.0		 2o4kA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		11 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.54A 2o4kB-2fmbA:
15.1		 2o4kB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.77A 2o4kB-2fmbA:
15.1		 2o4kB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4L_A_TPVA403_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  53
GLY A  55
VAL A  56
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.51A 2o4lA-2fmbA:
15.0		 2o4lA-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4L_A_TPVA403_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  55
VAL A  56
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.49A 2o4lA-2fmbA:
15.0		 2o4lA-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4L_A_TPVA403_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		12 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
VAL A  56
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.68A 2o4lB-2fmbA:
14.9		 2o4lB-2fmbA:
33.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2O4N_A_TPVA300_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.49A 2o4nA-2fmbA:
15.4		 2o4nA-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2O4N_A_TPVA300_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ILE A  85
ILE A  53
GLY A  55
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
 1.38A 2o4nA-2fmbA:
15.4		 2o4nA-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2O4N_A_TPVA300_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 8 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  55
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
 0.50A 2o4nB-2fmbA:
15.0		 2o4nB-2fmbA:
29.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4P_A_TPVA300_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.46A 2o4pA-2fmbA:
15.0		 2o4pA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4P_A_TPVA300_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  55
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.53A 2o4pB-2fmbA:
15.0		 2o4pB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.51A 2o4sA-2fmbA:
15.0		 2o4sA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ASP A  25
GLY A  27
GLY A  54
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.75A 2o4sA-2fmbA:
15.0		 2o4sA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ARG A   8
ASP A  25
GLY A  27
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.60A 2o4sB-2fmbA:
15.1		 2o4sB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.51A 2o4sB-2fmbA:
15.1		 2o4sB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.48A 2o4sB-2fmbA:
15.1		 2o4sB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.39A 2pymA-2fmbA:
15.1		 2pymA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.46A 2pymB-2fmbA:
15.1		 2pymB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.45A 2pynA-2fmbA:
15.3		 2pynA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.47A 2pynB-2fmbA:
15.3		 2pynB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 9 ASP A  25
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.44A 2q5kA-2fmbA:
14.9		 2q5kA-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 ASP A  25
ALA A  28
VAL A  32
GLY A  54
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.80A 2q5kA-2fmbA:
14.9		 2q5kA-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
PRO A  86
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
 0.55A 2q5kB-2fmbA:
14.9		 2q5kB-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.62A 2q5kB-2fmbA:
14.9		 2q5kB-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
 LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
 0.92A 2q5kB-2fmbA:
14.9		 2q5kB-2fmbA:
33.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q63_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.92A 2q63A-2fmbA:
15.0		 2q63A-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q63_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.48A 2q63A-2fmbA:
15.0		 2q63A-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q63_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.50A 2q63B-2fmbA:
15.0		 2q63B-2fmbA:
29.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.45A 2q64A-2fmbA:
15.1		 2q64A-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_3
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.82A 2q64B-2fmbA:
15.0		 2q64B-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_3
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.50A 2q64B-2fmbA:
15.0		 2q64B-2fmbA:
30.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QAK_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.94A 2qakA-2fmbA:
15.0		 2qakA-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QAK_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.43A 2qakA-2fmbA:
15.0		 2qakA-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QAK_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.50A 2qakB-2fmbA:
15.0		 2qakB-2fmbA:
29.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.65A 2qhcA-2fmbA:
15.1		 2qhcA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 ASP A  25
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.48A 2qhcA-2fmbA:
15.1		 2qhcA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 11 ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.72A 2qhcA-2fmbA:
15.1		 2qhcA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_2
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.52A 2qhcB-2fmbA:
15.1		 2qhcB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
ILE A  53
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-4.6A)
LP1  A 201 (-4.2A)
 0.65A 2r5pA-2fmbA:
15.4		 2r5pA-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
VAL A  32
ILE A  53
GLY A  54
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.60A 2r5pA-2fmbA:
15.4		 2r5pA-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ARG A   8
ASP A  25
GLY A  27
ILE A  53
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.68A 2r5pB-2fmbA:
15.1		 2r5pB-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
ALA A  28
ASP A  29
VAL A  32
GLY A  54
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.03A 2r5pB-2fmbA:
15.1		 2r5pB-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.50A 2r5pB-2fmbA:
15.1		 2r5pB-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ILE A  53
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.62A 2r5pC-2fmbA:
15.4		 2r5pC-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
VAL A  32
ILE A  53
GLY A  54
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.59A 2r5pC-2fmbA:
15.4		 2r5pC-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ARG A   8
ASP A  25
GLY A  27
ILE A  53
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.68A 2r5pD-2fmbA:
15.1		 2r5pD-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  54
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.89A 2r5pD-2fmbA:
15.1		 2r5pD-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.45A 2r5pD-2fmbA:
15.1		 2r5pD-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ARG A   8
LEU A  23
ASP A  25
ILE A  53
PRO A  86
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
 0.85A 2r5qA-2fmbA:
15.3		 2r5qA-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 LEU A  23
ASP A  25
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.97A 2r5qA-2fmbA:
15.3		 2r5qA-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 LEU A  23
ASP A  25
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.59A 2r5qA-2fmbA:
15.3		 2r5qA-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.88A 2r5qB-2fmbA:
14.9		 2r5qB-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.42A 2r5qB-2fmbA:
14.9		 2r5qB-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ARG A   8
LEU A  23
ASP A  25
ILE A  53
PRO A  86
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
 0.85A 2r5qC-2fmbA:
15.3		 2r5qC-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 LEU A  23
ASP A  25
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.97A 2r5qC-2fmbA:
15.3		 2r5qC-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 LEU A  23
ASP A  25
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.59A 2r5qC-2fmbA:
15.3		 2r5qC-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.88A 2r5qD-2fmbA:
14.9		 2r5qD-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.32A 2r5qD-2fmbA:
14.9		 2r5qD-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.41A 2rkfA-2fmbA:
15.1		 2rkfA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_2
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.37A 2rkfB-2fmbA:
15.1		 2rkfB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_2
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.73A 2rkfB-2fmbA:
15.1		 2rkfB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.65A 2rkgA-2fmbA:
15.7		 2rkgA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_1
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.34A 2rkgA-2fmbA:
15.7		 2rkgA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_2
(PROTEASE RETROPEPSIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.33A 2rkgB-2fmbA:
15.7		 2rkgB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.49A 2z54A-2fmbA:
15.1		 2z54A-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.78A 2z54B-2fmbA:
15.1		 2z54B-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.47A 2z54B-2fmbA:
15.1		 2z54B-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3BVB_B_017B401_1
(PROTEASE
(RETROPEPSIN))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ARG A   8
LEU A  23
GLY A  27
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.8A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.79A 3bvbA-2fmbA:
14.9		 3bvbA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3BVB_B_017B401_1
(PROTEASE
(RETROPEPSIN))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
GLY A  27
ALA A  28
VAL A  32
GLY A  54
VAL A  87
ILE A  89
 None
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.01A 3bvbA-2fmbA:
14.9		 3bvbA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3BVB_B_017B401_1
(PROTEASE
(RETROPEPSIN))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.47A 3bvbA-2fmbA:
14.9		 3bvbA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3BVB_B_017B401_2
(PROTEASE
(RETROPEPSIN))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
VAL A  87
ILE A  89
 None
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.88A 3bvbB-2fmbA:
15.0		 3bvbB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3BVB_B_017B401_2
(PROTEASE
(RETROPEPSIN))		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.45A 3bvbB-2fmbA:
15.0		 3bvbB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.52A 3cywA-2fmbA:
15.0		 3cywA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.46A 3cywB-2fmbA:
15.0		 3cywB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
VAL A  56
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.54A 3cyxA-2fmbA:
14.7		 3cyxA-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_3
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ALA A  28
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.63A 3cyxB-2fmbA:
15.0		 3cyxB-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_3
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		11 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ILE A  53
GLY A  54
GLY A  55
VAL A  56
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.56A 3cyxB-2fmbA:
15.0		 3cyxB-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.03A 3d1xA-2fmbA:
14.9		 3d1xA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.60A 3d1xA-2fmbA:
14.9		 3d1xA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.49A 3d1xB-2fmbA:
15.0		 3d1xB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Y_A_ROCA201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.05A 3d1yA-2fmbA:
14.9		 3d1yA-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Y_A_ROCA201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.52A 3d1yA-2fmbA:
14.9		 3d1yA-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Y_A_ROCA201_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 9 ARG A   8
LEU A  23
ASP A  25
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.62A 3d1yB-2fmbA:
14.9		 3d1yB-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
ALA A  28
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.99A 3d1zA-2fmbA:
15.0		 3d1zA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.46A 3d1zA-2fmbA:
15.0		 3d1zA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.37A 3d1zB-2fmbA:
14.9		 3d1zB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.42A 3d20A-2fmbA:
15.0		 3d20A-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.45A 3d20B-2fmbA:
14.9		 3d20B-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.54A 3ebzA-2fmbA:
15.7		 3ebzA-2fmbA:
37.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.39A 3ebzA-2fmbA:
15.7		 3ebzA-2fmbA:
37.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
 0.26A 3ebzB-2fmbA:
15.5		 3ebzB-2fmbA:
37.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_B_478B200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.84A 3ekpA-2fmbA:
15.3		 3ekpA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_B_478B200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.35A 3ekpA-2fmbA:
15.3		 3ekpA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_B_478B200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.77A 3ekpB-2fmbA:
15.3		 3ekpB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_B_478B200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 1.41A 3ekpB-2fmbA:
15.3		 3ekpB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_B_478B200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.35A 3ekpB-2fmbA:
15.3		 3ekpB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 1.46A 3ekpC-2fmbA:
15.2		 3ekpC-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.89A 3ekpC-2fmbA:
15.2		 3ekpC-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.51A 3ekpC-2fmbA:
15.2		 3ekpC-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 1.32A 3ekpD-2fmbA:
15.2		 3ekpD-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.83A 3ekpD-2fmbA:
15.2		 3ekpD-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.47A 3ekpD-2fmbA:
15.2		 3ekpD-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.80A 3ekqA-2fmbA:
14.9		 3ekqA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.52A 3ekqA-2fmbA:
14.9		 3ekqA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 9 ARG A   8
LEU A  23
ASP A  25
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.65A 3ekqB-2fmbA:
14.9		 3ekqB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ASP A  25
VAL A  32
GLY A  54
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.83A 3ekqB-2fmbA:
14.9		 3ekqB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
 0.89A 3ektA-2fmbA:
15.2		 3ektA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
 0.37A 3ektA-2fmbA:
15.2		 3ektA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.80A 3ektB-2fmbA:
15.2		 3ektB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.40A 3ektB-2fmbA:
15.2		 3ektB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 1.37A 3ektC-2fmbA:
15.3		 3ektC-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.39A 3ektC-2fmbA:
15.3		 3ektC-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.82A 3ektC-2fmbA:
15.3		 3ektC-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.36A 3ektD-2fmbA:
15.4		 3ektD-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 1.31A 3ekvA-2fmbA:
15.0		 3ekvA-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.76A 3ekvA-2fmbA:
15.0		 3ekvA-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.43A 3ekvA-2fmbA:
15.0		 3ekvA-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 ASP A  25
ALA A  28
VAL A  32
GLY A  54
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.98A 3ekvB-2fmbA:
15.0		 3ekvB-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.61A 3ekvB-2fmbA:
15.0		 3ekvB-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 ARG A   8
ASP A  25
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.51A 3ekwA-2fmbA:
15.0		 3ekwA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 ASP A  25
ALA A  28
ASP A  29
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.79A 3ekwA-2fmbA:
15.0		 3ekwA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.51A 3ekwB-2fmbA:
14.9		 3ekwB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.93A 3ekxA-2fmbA:
15.2		 3ekxA-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.43A 3ekxA-2fmbA:
15.2		 3ekxA-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 ASP A  25
ALA A  28
VAL A  32
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.79A 3ekxB-2fmbA:
15.2		 3ekxB-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.53A 3ekxB-2fmbA:
15.2		 3ekxB-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.56A 3ekyA-2fmbA:
15.2		 3ekyA-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.85A 3ekyA-2fmbA:
15.2		 3ekyA-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 9 ARG A   8
ASP A  25
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.54A 3ekyB-2fmbA:
15.1		 3ekyB-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL0_A_1UNA201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.40A 3el0A-2fmbA:
14.5		 3el0A-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL0_A_1UNA201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 LEU A  23
ASP A  25
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.71A 3el0B-2fmbA:
14.7		 3el0B-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 11 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.41A 3el1A-2fmbA:
15.1		 3el1A-2fmbA:
34.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.60A 3el1B-2fmbA:
15.2		 3el1B-2fmbA:
34.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.54A 3el1B-2fmbA:
15.2		 3el1B-2fmbA:
34.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.74A 3el1B-2fmbA:
15.2		 3el1B-2fmbA:
34.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
 0.96A 3el4A-2fmbA:
15.1		 3el4A-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.44A 3el4A-2fmbA:
15.1		 3el4A-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 ARG A   8
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.61A 3el4B-2fmbA:
15.3		 3el4B-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
 0.77A 3el5A-2fmbA:
15.2		 3el5A-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.60A 3el5A-2fmbA:
15.2		 3el5A-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
 0.90A 3el5B-2fmbA:
14.9		 3el5B-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.45A 3el5B-2fmbA:
14.9		 3el5B-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 8 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  55
PRO A  86
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.45A 3el9A-2fmbA:
15.0		 3el9A-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.53A 3el9B-2fmbA:
15.3		 3el9B-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
 0.87A 3el9B-2fmbA:
15.3		 3el9B-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM3_B_478B200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.78A 3em3A-2fmbA:
15.2		 3em3A-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM3_B_478B200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.38A 3em3A-2fmbA:
15.2		 3em3A-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM3_B_478B200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.80A 3em3B-2fmbA:
15.0		 3em3B-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM3_B_478B200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 10 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.52A 3em3B-2fmbA:
15.0		 3em3B-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.45A 3em4A-2fmbA:
15.2		 3em4A-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.48A 3em4B-2fmbA:
15.2		 3em4B-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ASP A  25
ALA A  28
ASP A  29
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.96A 3em4B-2fmbA:
15.2		 3em4B-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.53A 3em4U-2fmbA:
15.2		 3em4U-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 10 ARG A   8
ASP A  25
ASP A  29
ILE A  53
GLY A  54
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.65A 3em4V-2fmbA:
15.2		 3em4V-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 ASP A  25
ASP A  29
GLY A  55
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.02A 3em4V-2fmbA:
15.2		 3em4V-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM6_A_017A200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
 0.81A 3em6A-2fmbA:
15.1		 3em6A-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM6_A_017A200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
VAL A  87
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.31A 3em6A-2fmbA:
15.1		 3em6A-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM6_A_017A200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  53
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.64A 3em6B-2fmbA:
14.9		 3em6B-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM6_A_017A200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.84A 3em6B-2fmbA:
14.9		 3em6B-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM6_A_017A200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.58A 3em6B-2fmbA:
14.9		 3em6B-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
PRO A  86
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.36A 3gguA-2fmbA:
15.3		 3gguA-2fmbA:
32.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
 0.19A 3gguB-2fmbA:
15.2		 3gguB-2fmbA:
32.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
 0.73A 3gguB-2fmbA:
15.2		 3gguB-2fmbA:
32.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_1
(GAG-POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.40A 3jvyA-2fmbA:
14.9		 3jvyA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_1
(GAG-POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.75A 3jvyA-2fmbA:
14.9		 3jvyA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_2
(GAG-POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.65A 3jvyB-2fmbA:
14.8		 3jvyB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_2
(GAG-POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.42A 3jvyB-2fmbA:
14.8		 3jvyB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JW2_A_017A401_1
(GAG-POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.45A 3jw2A-2fmbA:
15.2		 3jw2A-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JW2_A_017A401_1
(GAG-POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.91A 3jw2A-2fmbA:
15.2		 3jw2A-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JW2_A_017A401_2
(GAG-POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 1.33A 3jw2B-2fmbA:
14.9		 3jw2B-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JW2_A_017A401_2
(GAG-POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.87A 3jw2B-2fmbA:
14.9		 3jw2B-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JW2_A_017A401_2
(GAG-POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.45A 3jw2B-2fmbA:
14.9		 3jw2B-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_B_ROCB201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.80A 3k4vA-2fmbA:
15.2		 3k4vA-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_B_ROCB201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.54A 3k4vA-2fmbA:
15.2		 3k4vA-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_B_ROCB201_3
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.95A 3k4vB-2fmbA:
15.0		 3k4vB-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_B_ROCB201_3
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.52A 3k4vB-2fmbA:
15.0		 3k4vB-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.59A 3k4vC-2fmbA:
15.2		 3k4vC-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.60A 3k4vC-2fmbA:
15.2		 3k4vC-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_3
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.55A 3k4vD-2fmbA:
14.9		 3k4vD-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.76A 3lzsA-2fmbA:
15.2		 3lzsA-2fmbA:
34.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.47A 3lzsA-2fmbA:
15.2		 3lzsA-2fmbA:
34.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.83A 3lzsB-2fmbA:
15.1		 3lzsB-2fmbA:
34.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.52A 3lzsB-2fmbA:
15.1		 3lzsB-2fmbA:
34.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.51A 3lzuA-2fmbA:
15.0		 3lzuA-2fmbA:
34.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.49A 3lzuB-2fmbA:
14.9		 3lzuB-2fmbA:
34.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.86A 3lzuB-2fmbA:
14.9		 3lzuB-2fmbA:
34.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
 0.83A 3lzvA-2fmbA:
15.1		 3lzvA-2fmbA:
35.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.48A 3lzvA-2fmbA:
15.1		 3lzvA-2fmbA:
35.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 ASP A  25
ALA A  28
VAL A  32
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.07A 3lzvB-2fmbA:
15.4		 3lzvB-2fmbA:
35.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.46A 3lzvB-2fmbA:
15.4		 3lzvB-2fmbA:
35.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.34A 3mwsA-2fmbA:
15.7		 3mwsA-2fmbA:
35.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.58A 3mwsB-2fmbA:
15.7		 3mwsB-2fmbA:
35.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N3I_A_ROCA201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
VAL A  87
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.33A 3n3iA-2fmbA:
10.6		 3n3iA-2fmbA:
23.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_A_ROCA101_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 1.49A 3ndtA-2fmbA:
15.2		 3ndtA-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_A_ROCA101_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.97A 3ndtA-2fmbA:
15.2		 3ndtA-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_A_ROCA101_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.53A 3ndtA-2fmbA:
15.2		 3ndtA-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_A_ROCA101_3
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.89A 3ndtB-2fmbA:
15.2		 3ndtB-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_A_ROCA101_3
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.95A 3ndtB-2fmbA:
15.2		 3ndtB-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_A_ROCA101_3
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.50A 3ndtB-2fmbA:
15.2		 3ndtB-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.52A 3ndtC-2fmbA:
15.2		 3ndtC-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.54A 3ndtC-2fmbA:
15.2		 3ndtC-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ALA A  28
VAL A  32
GLY A  54
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.92A 3ndtD-2fmbA:
15.0		 3ndtD-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.51A 3ndtD-2fmbA:
15.0		 3ndtD-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.52A 3nduA-2fmbA:
15.2		 3nduA-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.49A 3nduB-2fmbA:
15.1		 3nduB-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.56A 3nduC-2fmbA:
15.3		 3nduC-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.59A 3nduC-2fmbA:
15.3		 3nduC-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.55A 3nduD-2fmbA:
14.4		 3nduD-2fmbA:
33.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.63A 3ndwA-2fmbA:
14.9		 3ndwA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 GLY A  27
ALA A  28
VAL A  32
GLY A  54
PRO A  86
 LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
 0.95A 3ndwA-2fmbA:
14.9		 3ndwA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  29
ILE A  53
GLY A  55
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.58A 3ndwB-2fmbA:
15.1		 3ndwB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.61A 3ndxA-2fmbA:
15.0		 3ndxA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.56A 3ndxB-2fmbA:
15.2		 3ndxB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
GLY A  54
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.72A 3ndxB-2fmbA:
15.2		 3ndxB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  54
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.81A 3nu3A-2fmbA:
14.8		 3nu3A-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.53A 3nu3A-2fmbA:
14.8		 3nu3A-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.42A 3nu3B-2fmbA:
14.9		 3nu3B-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 LEU A  23
GLY A  27
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-3.8A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.75A 3nu3B-2fmbA:
14.9		 3nu3B-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 ASP A  25
ALA A  28
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.08A 3nu4A-2fmbA:
14.9		 3nu4A-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 ASP A  25
ALA A  28
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.53A 3nu4A-2fmbA:
14.9		 3nu4A-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.70A 3nu4B-2fmbA:
14.8		 3nu4B-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.29A 3nu4B-2fmbA:
14.8		 3nu4B-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  54
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.84A 3nu5A-2fmbA:
14.9		 3nu5A-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
VAL A  56
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.50A 3nu5A-2fmbA:
14.9		 3nu5A-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
VAL A  56
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-4.2A)
 0.44A 3nu5B-2fmbA:
15.0		 3nu5B-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
VAL A  32
ILE A  53
GLY A  55
VAL A  56
PRO A  86
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-3.9A)
 0.58A 3nu5B-2fmbA:
15.0		 3nu5B-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 ASP A  25
ALA A  28
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.01A 3nu6A-2fmbA:
14.9		 3nu6A-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.52A 3nu6A-2fmbA:
14.9		 3nu6A-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.30A 3nu6B-2fmbA:
15.0		 3nu6B-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 8 ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.33A 3nu9A-2fmbA:
15.0		 3nu9A-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 8 ASP A  25
ALA A  28
VAL A  32
PRO A  86
VAL A  87
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.64A 3nu9A-2fmbA:
15.0		 3nu9A-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.35A 3nu9B-2fmbA:
14.9		 3nu9B-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 ASP A  25
ALA A  28
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.04A 3nujA-2fmbA:
15.0		 3nujA-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.47A 3nujA-2fmbA:
15.0		 3nujA-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.77A 3nujB-2fmbA:
14.9		 3nujB-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.36A 3nujB-2fmbA:
14.9		 3nujB-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 ASP A  25
ALA A  28
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.09A 3nuoA-2fmbA:
14.9		 3nuoA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 ASP A  25
ALA A  28
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.50A 3nuoA-2fmbA:
14.9		 3nuoA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.38A 3nuoB-2fmbA:
14.8		 3nuoB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGP_A_017A200_1
(FIV PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
 0.62A 3ogpA-2fmbA:
15.4		 3ogpA-2fmbA:
33.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGP_A_017A200_1
(FIV PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
 0.37A 3ogpA-2fmbA:
15.4		 3ogpA-2fmbA:
33.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGP_A_017A200_2
(FIV PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 ASP A  25
ALA A  28
VAL A  32
GLY A  54
VAL A  87
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
 0.88A 3ogpB-2fmbA:
15.6		 3ogpB-2fmbA:
33.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGP_A_017A200_2
(FIV PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  55
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.58A 3ogpB-2fmbA:
15.6		 3ogpB-2fmbA:
33.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGP_B_017B200_1
(FIV PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 LEU A  23
ASP A  25
ALA A  28
GLY A  54
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
 0.62A 3ogpA-2fmbA:
15.4		 3ogpA-2fmbA:
33.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGP_B_017B200_1
(FIV PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 LEU A  23
ASP A  25
ALA A  28
GLY A  55
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.64A 3ogpA-2fmbA:
15.4		 3ogpA-2fmbA:
33.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGP_B_017B200_2
(FIV PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
 0.83A 3ogpB-2fmbA:
15.6		 3ogpB-2fmbA:
33.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGP_B_017B200_2
(FIV PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
 0.17A 3ogpB-2fmbA:
15.6		 3ogpB-2fmbA:
33.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGQ_A_AB1A200_1
(FIV PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
VAL A  32
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
 0.91A 3ogqA-2fmbA:
15.2		 3ogqA-2fmbA:
33.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGQ_A_AB1A200_1
(FIV PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
VAL A  32
GLY A  55
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
 0.47A 3ogqA-2fmbA:
15.2		 3ogqA-2fmbA:
33.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGQ_A_AB1A200_2
(FIV PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
 0.54A 3ogqB-2fmbA:
15.6		 3ogqB-2fmbA:
33.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.61A 3oxcA-2fmbA:
14.6		 3oxcA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.80A 3oxcA-2fmbA:
14.6		 3oxcA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  55
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.63A 3oxcB-2fmbA:
15.1		 3oxcB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  55
VAL A  87
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.53A 3oxcB-2fmbA:
15.1		 3oxcB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
ALA A  28
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.66A 3oxcB-2fmbA:
15.1		 3oxcB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.59A 3oxcB-2fmbA:
15.1		 3oxcB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.65A 3oxcB-2fmbA:
15.1		 3oxcB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  55
PRO A  86
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.56A 3oxcB-2fmbA:
15.1		 3oxcB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.68A 3oxvA-2fmbA:
15.6		 3oxvA-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  55
VAL A  56
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.48A 3oxvA-2fmbA:
15.6		 3oxvA-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 ASP A  25
ALA A  28
VAL A  32
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.14A 3oxvB-2fmbA:
15.4		 3oxvB-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 10 ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
VAL A  56
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.54A 3oxvB-2fmbA:
15.4		 3oxvB-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_C_478C200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.72A 3oxvC-2fmbA:
15.4		 3oxvC-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_C_478C200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
VAL A  56
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-4.2A)
 0.47A 3oxvC-2fmbA:
15.4		 3oxvC-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_C_478C200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 ASP A  25
ALA A  28
VAL A  32
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.14A 3oxvD-2fmbA:
15.5		 3oxvD-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_C_478C200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 11 ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
VAL A  56
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.57A 3oxvD-2fmbA:
15.5		 3oxvD-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_B_017B200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
 0.85A 3oxwA-2fmbA:
15.4		 3oxwA-2fmbA:
37.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_B_017B200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
VAL A  56
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 ( 4.9A)
 0.53A 3oxwA-2fmbA:
15.4		 3oxwA-2fmbA:
37.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_B_017B200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.91A 3oxwB-2fmbA:
15.6		 3oxwB-2fmbA:
37.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_B_017B200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 10 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
VAL A  56
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.34A 3oxwB-2fmbA:
15.6		 3oxwB-2fmbA:
37.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
VAL A  56
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 ( 4.9A)
 0.43A 3oxwC-2fmbA:
15.6		 3oxwC-2fmbA:
37.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
 0.72A 3oxwC-2fmbA:
15.6		 3oxwC-2fmbA:
37.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 1.46A 3oxwD-2fmbA:
15.3		 3oxwD-2fmbA:
37.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.91A 3oxwD-2fmbA:
15.3		 3oxwD-2fmbA:
37.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 10 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  55
VAL A  56
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.43A 3oxwD-2fmbA:
15.3		 3oxwD-2fmbA:
37.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		12 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
VAL A  56
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.46A 3oxxA-2fmbA:
15.1		 3oxxA-2fmbA:
37.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		11 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  53
GLY A  55
VAL A  56
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.51A 3oxxB-2fmbA:
15.4		 3oxxB-2fmbA:
37.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		12 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
VAL A  56
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.47A 3oxxC-2fmbA:
14.8		 3oxxC-2fmbA:
37.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.56A 3oxxD-2fmbA:
15.6		 3oxxD-2fmbA:
37.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  53
GLY A  55
VAL A  56
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.50A 3oxxD-2fmbA:
15.6		 3oxxD-2fmbA:
37.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.84A 3oy4A-2fmbA:
15.0		 3oy4A-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 ARG A   8
LEU A  23
ASP A  29
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.40A 3oy4A-2fmbA:
15.0		 3oy4A-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 LEU A  23
ALA A  28
ASP A  29
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.44A 3oy4A-2fmbA:
15.0		 3oy4A-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.03A 3oy4A-2fmbA:
15.0		 3oy4A-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.55A 3oy4A-2fmbA:
15.0		 3oy4A-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
 0.78A 3oy4B-2fmbA:
15.0		 3oy4B-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.44A 3oy4B-2fmbA:
15.0		 3oy4B-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.76A 3pwmA-2fmbA:
15.0		 3pwmA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.44A 3pwmA-2fmbA:
15.0		 3pwmA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.48A 3pwmB-2fmbA:
15.1		 3pwmB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.51A 3pwrA-2fmbA:
14.9		 3pwrA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_3
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.46A 3pwrB-2fmbA:
15.1		 3pwrB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_3
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.70A 3pwrB-2fmbA:
15.1		 3pwrB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.27A 3s43B-2fmbA:
14.9		 3s43B-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ASP A  25
ALA A  28
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.38A 3s45A-2fmbA:
15.7		 3s45A-2fmbA:
37.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.38A 3s45B-2fmbA:
15.7		 3s45B-2fmbA:
37.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
 0.76A 3s53A-2fmbA:
14.9		 3s53A-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
 0.21A 3s53A-2fmbA:
14.9		 3s53A-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.26A 3s53B-2fmbA:
15.0		 3s53B-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S54_B_017B201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.63A 3s54A-2fmbA:
15.0		 3s54A-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S54_B_017B201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.72A 3s54A-2fmbA:
15.0		 3s54A-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S54_B_017B201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.24A 3s54A-2fmbA:
15.0		 3s54A-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S54_B_017B201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.82A 3s54B-2fmbA:
15.0		 3s54B-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S54_B_017B201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.32A 3s54B-2fmbA:
15.0		 3s54B-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.36A 3s56A-2fmbA:
14.6		 3s56A-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 ARG A   8
LEU A  23
ASP A  25
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.41A 3s56B-2fmbA:
14.9		 3s56B-2fmbA:
30.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SM2_A_478A126_2
(GAG-PRO-POL
POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 11 ASP A  25
ALA A  28
GLY A  54
LEU A  81
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.9A)
 0.88A 3sm2B-2fmbA:
12.7		 3sm2B-2fmbA:
26.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SM2_A_478A126_2
(GAG-PRO-POL
POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 ASP A  25
ALA A  28
VAL A  32
GLY A  55
LEU A  81
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
None
LP1  A 201 (-3.9A)
 0.85A 3sm2B-2fmbA:
12.7		 3sm2B-2fmbA:
26.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SO9_A_017A100_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		4 / 8 GLY A  27
ALA A  28
ASP A  29
GLY A  55
 LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
 0.37A 3so9A-2fmbA:
14.6		 3so9A-2fmbA:
31.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SO9_A_017A100_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.76A 3so9B-2fmbA:
14.5		 3so9B-2fmbA:
31.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SO9_A_017A100_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 LEU A  23
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
 None
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.75A 3so9B-2fmbA:
14.5		 3so9B-2fmbA:
31.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_A_TPVA100_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 ARG A   8
LEU A  23
ALA A  28
ASP A  29
ILE A  53
GLY A  55
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
 0.54A 3spkA-2fmbA:
15.0		 3spkA-2fmbA:
31.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_A_TPVA100_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 LEU A  23
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
 None
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.73A 3spkA-2fmbA:
15.0		 3spkA-2fmbA:
31.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_A_TPVA100_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		4 / 7 ARG A   8
LEU A  23
ALA A  28
GLY A  55
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
 0.49A 3spkB-2fmbA:
15.0		 3spkB-2fmbA:
31.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_B_TPVB100_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ARG A   8
LEU A  23
ALA A  28
VAL A  32
GLY A  55
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
 0.64A 3spkA-2fmbA:
15.0		 3spkA-2fmbA:
31.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_B_TPVB100_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 LEU A  23
ALA A  28
VAL A  32
GLY A  55
PRO A  86
 None
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.70A 3spkA-2fmbA:
15.0		 3spkA-2fmbA:
31.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_B_TPVB100_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ARG A   8
LEU A  23
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.62A 3spkB-2fmbA:
15.0		 3spkB-2fmbA:
31.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3C_A_017A201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
 0.26A 3t3cA-2fmbA:
15.2		 3t3cA-2fmbA:
29.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3C_A_017A201_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.42A 3t3cB-2fmbA:
15.3		 3t3cB-2fmbA:
29.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.52A 3tkgA-2fmbA:
13.3		 3tkgA-2fmbA:
32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.46A 3tkgB-2fmbA:
15.2		 3tkgB-2fmbA:
32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.51A 3tkgB-2fmbA:
15.2		 3tkgB-2fmbA:
32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.56A 3tkgC-2fmbA:
14.7		 3tkgC-2fmbA:
32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ARG A   8
LEU A  23
ALA A  28
VAL A  32
ILE A  53
GLY A  55
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.65A 3tkgD-2fmbA:
15.1		 3tkgD-2fmbA:
32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
VAL A  87
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.53A 3tkgD-2fmbA:
15.1		 3tkgD-2fmbA:
32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.42A 3tkwA-2fmbA:
15.1		 3tkwA-2fmbA:
32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.83A 3tkwB-2fmbA:
14.3		 3tkwB-2fmbA:
32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.49A 3tkwB-2fmbA:
14.3		 3tkwB-2fmbA:
32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TL9_A_ROCA401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.02A 3tl9A-2fmbA:
15.1		 3tl9A-2fmbA:
32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TL9_A_ROCA401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.53A 3tl9A-2fmbA:
15.1		 3tl9A-2fmbA:
32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TL9_A_ROCA401_3
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		11 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.57A 3tl9B-2fmbA:
14.3		 3tl9B-2fmbA:
32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TL9_A_ROCA401_3
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.70A 3tl9B-2fmbA:
14.3		 3tl9B-2fmbA:
32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.37A 3ttpA-2fmbA:
15.9		 3ttpA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.62A 3ttpA-2fmbA:
15.9		 3ttpA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.38A 3ttpB-2fmbA:
15.9		 3ttpB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.64A 3ttpB-2fmbA:
15.9		 3ttpB-2fmbA:
31.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U7S_A_017A201_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
 0.27A 3u7sA-2fmbA:
15.1		 3u7sA-2fmbA:
27.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U7S_A_017A201_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
 0.73A 3u7sA-2fmbA:
15.1		 3u7sA-2fmbA:
27.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U7S_A_017A201_2
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 ARG A   8
ASP A  25
ALA A  28
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.57A 3u7sB-2fmbA:
15.4		 3u7sB-2fmbA:
27.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U7S_A_017A202_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  55
PRO A  86
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 1.41A 3u7sA-2fmbA:
15.1		 3u7sA-2fmbA:
27.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U7S_A_017A202_1
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ILE A  53
GLY A  55
PRO A  86
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.50A 3u7sA-2fmbA:
15.1		 3u7sA-2fmbA:
27.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U7S_A_017A202_2
(POL POLYPROTEIN)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
 0.30A 3u7sB-2fmbA:
15.4		 3u7sB-2fmbA:
27.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.40A 3ucbA-2fmbA:
16.0		 3ucbA-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.36A 3ucbB-2fmbA:
15.2		 3ucbB-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA401_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
 0.81A 3ufnA-2fmbA:
15.7		 3ufnA-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA401_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
GLY A  55
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.33A 3ufnA-2fmbA:
15.7		 3ufnA-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA401_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		4 / 7 ARG A   8
ASP A  25
GLY A  55
VAL A  87
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.60A 3ufnB-2fmbA:
15.1		 3ufnB-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3WSJ_A_MK1A201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.49A 3wsjA-2fmbA:
11.0		 3wsjA-2fmbA:
31.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3WSJ_A_MK1A201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
VAL A  32
LEU A  81
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
None
LP1  A 201 (-4.2A)
 0.81A 3wsjA-2fmbA:
11.0		 3wsjA-2fmbA:
31.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3WSJ_A_MK1A201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 7 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.2A)
 0.55A 3wsjB-2fmbA:
12.5		 3wsjB-2fmbA:
31.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3WSJ_A_MK1A201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 7 ARG A   8
LEU A  23
ASP A  25
VAL A  60
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
None
LP1  A 201 (-4.2A)
 1.19A 3wsjB-2fmbA:
12.5		 3wsjB-2fmbA:
31.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_1
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  53
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.71A 4dqbA-2fmbA:
15.0		 4dqbA-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_1
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.99A 4dqbA-2fmbA:
15.0		 4dqbA-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_1
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.65A 4dqbA-2fmbA:
15.0		 4dqbA-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_2
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
 0.78A 4dqbB-2fmbA:
15.2		 4dqbB-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_2
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.56A 4dqbB-2fmbA:
15.2		 4dqbB-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_1
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.79A 4dqcA-2fmbA:
15.1		 4dqcA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_1
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.60A 4dqcA-2fmbA:
15.1		 4dqcA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_2
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
 0.81A 4dqcB-2fmbA:
15.2		 4dqcB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_2
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
 0.36A 4dqcB-2fmbA:
15.2		 4dqcB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_1
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.66A 4dqeA-2fmbA:
15.1		 4dqeA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_1
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.05A 4dqeA-2fmbA:
15.1		 4dqeA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_1
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.55A 4dqeA-2fmbA:
15.1		 4dqeA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_2
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
 0.80A 4dqeB-2fmbA:
15.1		 4dqeB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_2
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.58A 4dqeB-2fmbA:
15.1		 4dqeB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_1
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  53
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.62A 4dqfA-2fmbA:
14.3		 4dqfA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_1
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.01A 4dqfA-2fmbA:
14.3		 4dqfA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_1
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.50A 4dqfA-2fmbA:
14.3		 4dqfA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_2
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.77A 4dqfB-2fmbA:
14.9		 4dqfB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_2
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.44A 4dqfB-2fmbA:
14.9		 4dqfB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_1
(WILD-TYPE HIV-1
PROTEASE DIMER)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 11 ARG A   8
LEU A  23
ASP A  25
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.84A 4dqhA-2fmbA:
15.0		 4dqhA-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_1
(WILD-TYPE HIV-1
PROTEASE DIMER)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.09A 4dqhA-2fmbA:
15.0		 4dqhA-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_1
(WILD-TYPE HIV-1
PROTEASE DIMER)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.65A 4dqhA-2fmbA:
15.0		 4dqhA-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_2
(WILD-TYPE HIV-1
PROTEASE DIMER)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
 0.77A 4dqhB-2fmbA:
15.1		 4dqhB-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_2
(WILD-TYPE HIV-1
PROTEASE DIMER)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.55A 4dqhB-2fmbA:
15.1		 4dqhB-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4EYR_B_RITB301_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		4 / 7 LEU A  23
ALA A  28
ASP A  29
VAL A  32
 None
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
 0.27A 4eyrA-2fmbA:
13.9		 4eyrA-2fmbA:
30.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4EYR_B_RITB301_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		4 / 8 ARG A   8
GLY A  27
ALA A  28
ASP A  29
 LP1  A 201 (-3.5A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
 0.39A 4eyrB-2fmbA:
13.9		 4eyrB-2fmbA:
30.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4EYR_B_RITB301_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		4 / 8 GLY A  27
ALA A  28
ASP A  29
PRO A  86
 LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
 0.41A 4eyrB-2fmbA:
13.9		 4eyrB-2fmbA:
30.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.39A 4hlaA-2fmbA:
15.3		 4hlaA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.52A 4hlaA-2fmbA:
15.3		 4hlaA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.34A 4hlaB-2fmbA:
15.3		 4hlaB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.50A 4hlaB-2fmbA:
15.3		 4hlaB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4J5J_B_478B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 ASP A  25
ALA A  28
GLY A  55
PRO A  86
VAL A  87
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.47A 4j5jB-2fmbA:
15.4		 4j5jB-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.81A 4jecA-2fmbA:
15.0		 4jecA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.47A 4jecA-2fmbA:
15.0		 4jecA-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.62A 4jecB-2fmbA:
14.9		 4jecB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.43A 4jecB-2fmbA:
14.9		 4jecB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_3
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		3 / 3 ASP A  29
LEU A  81
VAL A  87
 LP1  A 201 (-3.6A)
None
LP1  A 201 ( 4.9A)
 0.41A 4jecB-2fmbA:
14.9		 4jecB-2fmbA:
33.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1A_A_AB1A101_1
(MDR769 HIV-1
PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 11 ARG A   8
GLY A  27
ALA A  28
ASP A  29
PRO A  86
 LP1  A 201 (-3.5A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
 0.66A 4l1aA-2fmbA:
13.5		 4l1aA-2fmbA:
30.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 8 ASP A  25
ALA A  28
ASP A  29
GLY A  55
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 1.17A 4ll3A-2fmbA:
15.1		 4ll3A-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 8 ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.81A 4ll3A-2fmbA:
15.1		 4ll3A-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 8 ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.47A 4ll3A-2fmbA:
15.1		 4ll3A-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 1.28A 4ll3B-2fmbA:
15.1		 4ll3B-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.34A 4ll3B-2fmbA:
15.1		 4ll3B-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.81A 4ll3B-2fmbA:
15.1		 4ll3B-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 1.24A 4ll3A-2fmbA:
15.1		 4ll3A-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.34A 4ll3A-2fmbA:
15.1		 4ll3A-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.83A 4ll3A-2fmbA:
15.1		 4ll3A-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 9 ARG A   8
ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.59A 4ll3B-2fmbA:
15.1		 4ll3B-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.79A 4ll3B-2fmbA:
15.1		 4ll3B-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.95A 4njtA-2fmbA:
15.0		 4njtA-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.42A 4njtA-2fmbA:
15.0		 4njtA-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
 0.86A 4njtB-2fmbA:
15.4		 4njtB-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
 0.43A 4njtB-2fmbA:
15.4		 4njtB-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.89A 4njtC-2fmbA:
15.1		 4njtC-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.46A 4njtC-2fmbA:
15.1		 4njtC-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
 0.34A 4njtD-2fmbA:
15.3		 4njtD-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_A_TPVA500_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.50A 4njuA-2fmbA:
15.0		 4njuA-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_A_TPVA500_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.75A 4njuB-2fmbA:
15.4		 4njuB-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_C_TPVC500_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.52A 4njuC-2fmbA:
15.0		 4njuC-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_C_TPVC500_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.75A 4njuD-2fmbA:
15.4		 4njuD-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.41A 4njvA-2fmbA:
15.0		 4njvA-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.48A 4njvA-2fmbA:
15.0		 4njvA-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 ARG A   8
ASP A  25
GLY A  27
ASP A  29
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.50A 4njvB-2fmbA:
15.2		 4njvB-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 ASP A  25
GLY A  27
VAL A  32
GLY A  54
PRO A  86
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.85A 4njvB-2fmbA:
15.2		 4njvB-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 11 ARG A   8
ASP A  25
GLY A  27
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.54A 4njvC-2fmbA:
15.0		 4njvC-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 11 ASP A  25
GLY A  27
VAL A  32
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.76A 4njvC-2fmbA:
15.0		 4njvC-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ALA A  28
VAL A  32
GLY A  54
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.80A 4njvD-2fmbA:
15.2		 4njvD-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.52A 4njvD-2fmbA:
15.2		 4njvD-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_1
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
 0.81A 4q1wA-2fmbA:
15.0		 4q1wA-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_1
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.34A 4q1wA-2fmbA:
15.0		 4q1wA-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_2
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 ASP A  25
ALA A  28
VAL A  32
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.22A 4q1wB-2fmbA:
14.8		 4q1wB-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_2
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 ASP A  25
ALA A  28
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.64A 4q1wB-2fmbA:
14.8		 4q1wB-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_1
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
 0.75A 4q1xA-2fmbA:
15.0		 4q1xA-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_1
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.54A 4q1xA-2fmbA:
15.0		 4q1xA-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_2
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.12A 4q1xB-2fmbA:
15.0		 4q1xB-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_2
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
ALA A  28
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.60A 4q1xB-2fmbA:
15.0		 4q1xB-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_1
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
 0.73A 4q1yA-2fmbA:
15.1		 4q1yA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_1
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.30A 4q1yA-2fmbA:
15.1		 4q1yA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_2
(ASPARTYL PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
ALA A  28
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.46A 4q1yB-2fmbA:
15.0		 4q1yB-2fmbA:
31.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q5M_A_ROCA1101_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 GLY A  27
ASP A  29
ILE A  53
PRO A  86
VAL A  87
 LP1  A 201 (-3.8A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.62A 4q5mA-2fmbA:
12.7		 4q5mA-2fmbA:
24.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q5M_A_ROCA1101_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ARG A   8
ALA A  28
VAL A  32
GLY A  55
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.51A 4q5mA-2fmbA:
12.7		 4q5mA-2fmbA:
24.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q5M_A_ROCA1101_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 GLY A  27
ASP A  29
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.8A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.47A 4q5mA-2fmbA:
12.7		 4q5mA-2fmbA:
24.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QGI_A_ROCA101_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
VAL A  87
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.53A 4qgiA-2fmbA:
14.7		 4qgiA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QGI_A_ROCA101_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.64A 4qgiB-2fmbA:
15.0		 4qgiB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QGI_A_ROCA101_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 11 ASP A  25
ALA A  28
VAL A  32
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.69A 4qgiB-2fmbA:
15.0		 4qgiB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  54
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 1.07A 4rvjA-2fmbA:
14.9		 4rvjA-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.45A 4rvjA-2fmbA:
14.9		 4rvjA-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.83A 4rvjB-2fmbA:
15.2		 4rvjB-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.43A 4rvjB-2fmbA:
15.2		 4rvjB-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  54
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 1.09A 4rvjC-2fmbA:
15.0		 4rvjC-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.46A 4rvjC-2fmbA:
15.0		 4rvjC-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.83A 4rvjD-2fmbA:
15.2		 4rvjD-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.44A 4rvjD-2fmbA:
15.2		 4rvjD-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.57A 5e5jA-2fmbA:
15.1		 5e5jA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.28A 5e5jA-2fmbA:
15.1		 5e5jA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.55A 5e5jB-2fmbA:
15.0		 5e5jB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ILE A  85
GLY A  55
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
None
LP1  A 201 (-3.4A)
 1.33A 5e5jB-2fmbA:
15.0		 5e5jB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  54
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.92A 5e5jB-2fmbA:
15.0		 5e5jB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.83A 5e5kA-2fmbA:
15.1		 5e5kA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.34A 5e5kA-2fmbA:
15.1		 5e5kA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.29A 5e5kB-2fmbA:
15.0		 5e5kB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_2
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.69A 5e5kB-2fmbA:
15.0		 5e5kB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQX_A_ROCA101_1
(PROTEASE E35D-SQV)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.06A 5kqxA-2fmbA:
14.8		 5kqxA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQX_A_ROCA101_1
(PROTEASE E35D-SQV)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.60A 5kqxA-2fmbA:
14.8		 5kqxA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQX_A_ROCA101_2
(PROTEASE E35D-SQV)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 ARG A   8
LEU A  23
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.64A 5kqxB-2fmbA:
14.9		 5kqxB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQY_B_017B101_1
(PROTEASE E35D-DRV)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.51A 5kqyA-2fmbA:
14.9		 5kqyA-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQY_B_017B101_2
(PROTEASE E35D-DRV)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		4 / 7 GLY A  27
ALA A  28
ASP A  29
GLY A  55
 LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
 0.22A 5kqyB-2fmbA:
14.8		 5kqyB-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR0_A_478A101_1
(PROTEASE E35D-APV)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 ALA A  28
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.56A 5kr0A-2fmbA:
14.9		 5kr0A-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR0_A_478A101_2
(PROTEASE E35D-APV)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 LEU A  23
GLY A  27
ALA A  28
VAL A  32
GLY A  54
VAL A  87
 None
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
 0.80A 5kr0B-2fmbA:
14.8		 5kr0B-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR0_A_478A101_2
(PROTEASE E35D-APV)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 9 LEU A  23
GLY A  27
ALA A  28
VAL A  32
GLY A  55
VAL A  87
 None
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.45A 5kr0B-2fmbA:
14.8		 5kr0B-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR1_B_017B101_1
(PROTEASE PR5-DRV)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 10 LEU A  23
ILE A  53
GLY A  55
VAL A  87
ILE A  89
 None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.55A 5kr1A-2fmbA:
14.7		 5kr1A-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR1_B_017B101_2
(PROTEASE PR5-DRV)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 8 GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
 LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
 0.72A 5kr1B-2fmbA:
15.2		 5kr1B-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR1_B_017B101_2
(PROTEASE PR5-DRV)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 8 GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
 LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
 0.46A 5kr1B-2fmbA:
15.2		 5kr1B-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_2
(PROTEASE PR5-SQV)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 11 ARG A   8
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 1.15A 5kr2B-2fmbA:
14.7		 5kr2B-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_2
(PROTEASE PR5-SQV)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 11 ARG A   8
LEU A  23
GLY A  55
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 1.10A 5kr2B-2fmbA:
14.7		 5kr2B-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_2
(PROTEASE PR5-SQV)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 11 LEU A  23
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.49A 5kr2B-2fmbA:
14.7		 5kr2B-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_C_ROCC101_1
(PROTEASE PR5-SQV)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 9 ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.71A 5kr2C-2fmbA:
15.1		 5kr2C-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_C_ROCC101_2
(PROTEASE PR5-SQV)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 9 ARG A   8
LEU A  23
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.66A 5kr2D-2fmbA:
14.9		 5kr2D-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.40A 5t2zA-2fmbA:
15.0		 5t2zA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 1.28A 5t2zB-2fmbA:
14.9		 5t2zB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
 0.79A 5t2zB-2fmbA:
14.9		 5t2zB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.44A 5t2zB-2fmbA:
14.9		 5t2zB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.40A 5t8hA-2fmbA:
15.1		 5t8hA-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
PRO A  86
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.66A 5t8hB-2fmbA:
15.0		 5t8hB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  54
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.95A 5t8hB-2fmbA:
15.0		 5t8hB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.31A 5t8hB-2fmbA:
15.0		 5t8hB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_0
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.51A 6dgxA-2fmbA:
15.2		 6dgxA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_0
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.47A 6dgxA-2fmbA:
15.2		 6dgxA-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  55
LEU A  81
PRO A  86
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
None
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.48A 6dgxB-2fmbA:
15.1		 6dgxB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		3 / 3 GLY A  27
ASP A  29
ILE A  53
 LP1  A 201 (-3.8A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
 0.15A 6dgxB-2fmbA:
15.1		 6dgxB-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_0
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
VAL A  87
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.59A 6dh0A-2fmbA:
15.2		 6dh0A-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_0
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.52A 6dh0A-2fmbA:
15.2		 6dh0A-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
LEU A  81
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
None
LP1  A 201 (-3.9A)
 0.43A 6dh0B-2fmbA:
15.1		 6dh0B-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
LEU A  81
PRO A  86
VAL A  87
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
None
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.57A 6dh0B-2fmbA:
15.1		 6dh0B-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_2
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		3 / 3 LEU A  23
ASP A  29
ILE A  53
 None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
 0.61A 6dh0B-2fmbA:
15.1		 6dh0B-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_0
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.46A 6dh3A-2fmbA:
15.2		 6dh3A-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_0
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.51A 6dh3A-2fmbA:
15.2		 6dh3A-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.41A 6dh3B-2fmbA:
15.1		 6dh3B-2fmbA:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_0
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
VAL A  56
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.61A 6dh6A-2fmbA:
15.1		 6dh6A-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_0
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
VAL A  56
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.52A 6dh6A-2fmbA:
15.1		 6dh6A-2fmbA:
32.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
LEU A  81
PRO A  86
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
None
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
 0.44A 6dh6B-2fmbA:
15.1		 6dh6B-2fmbA:
32.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DIF_B_TPVB201_0
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.51A 6difA-2fmbA:
15.0		 6difA-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DIF_B_TPVB201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  53
GLY A  55
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
 0.50A 6difB-2fmbA:
15.0		 6difB-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DIF_B_TPVB201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
VAL A  87
ILE A  89
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.51A 6difB-2fmbA:
15.0		 6difB-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DIF_B_TPVB201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 LEU A  23
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
 None
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.64A 6difB-2fmbA:
15.0		 6difB-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DIL_B_TPVB201_0
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.51A 6dilA-2fmbA:
15.0		 6dilA-2fmbA:
28.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DIL_B_TPVB201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ALA A  28
VAL A  32
GLY A  54
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.85A 6dilB-2fmbA:
15.0		 6dilB-2fmbA:
28.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DIL_B_TPVB201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		11 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.62A 6dilB-2fmbA:
15.0		 6dilB-2fmbA:
28.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJ1_B_AB1B201_0
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.57A 6dj1A-2fmbA:
14.8		 6dj1A-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJ1_B_AB1B201_0
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 ASP A  25
GLY A  27
GLY A  54
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.65A 6dj1A-2fmbA:
14.8		 6dj1A-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJ1_B_AB1B201_0
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		6 / 12 ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.90A 6dj1A-2fmbA:
14.8		 6dj1A-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJ1_B_AB1B201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
PRO A  86
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
 0.58A 6dj1B-2fmbA:
15.0		 6dj1B-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJ1_B_AB1B201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.59A 6dj1B-2fmbA:
15.0		 6dj1B-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJ1_B_AB1B201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
PRO A  86
VAL A  87
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.55A 6dj1B-2fmbA:
15.0		 6dj1B-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJ1_B_AB1B201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
 LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
 0.94A 6dj1B-2fmbA:
15.0		 6dj1B-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJ2_B_AB1B201_0
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		9 / 10 ASP A  25
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 0.65A 6dj2A-2fmbA:
14.8		 6dj2A-2fmbA:
28.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJ2_B_AB1B201_0
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		7 / 10 ASP A  25
ALA A  28
VAL A  32
GLY A  54
PRO A  86
VAL A  87
ILE A  89
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
 1.13A 6dj2A-2fmbA:
14.8		 6dj2A-2fmbA:
28.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJ2_B_AB1B201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
PRO A  86
VAL A  87
 LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.64A 6dj2B-2fmbA:
15.0		 6dj2B-2fmbA:
28.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJ2_B_AB1B201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
PRO A  86
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
 0.57A 6dj2B-2fmbA:
15.0		 6dj2B-2fmbA:
28.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJ2_B_AB1B201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
PRO A  86
VAL A  87
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
 0.58A 6dj2B-2fmbA:
15.0		 6dj2B-2fmbA:
28.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJ2_B_AB1B201_1
(HIV-1 PROTEASE)		 2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE
(Equine
infectious
anemia
virus) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
 LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
 0.93A 6dj2B-2fmbA:
15.0		 6dj2B-2fmbA:
28.85